Beacon Pharmaceuticals Ltd. reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was BDT 2,191.17 million compared to BDT 2,077.82 million a year ago. Net income was BDT 370.86 million compared to BDT 246.33 million a year ago. Basic earnings per share from continuing operations was BDT 1.61 compared to BDT 1.07 a year ago.
For the six months, sales was BDT 4,207.05 million compared to BDT 4,342.72 million a year ago. Net income was BDT 599.65 million compared to BDT 598.3 million a year ago. Basic earnings per share from continuing operations was BDT 2.6 compared to BDT 2.59 a year ago.